Peter H Gann

Plain English
This study focused on a program called Men Moving Forward (MMF), designed to help Black men who have survived prostate cancer improve their health through better nutrition and physical activity. The program will include 200 participants and span 16 weeks, aiming to significantly improve their body composition and overall health compared to a control group. This research is important because it specifically targets a group that often faces higher rates of prostate cancer and related health issues, providing tailored support that could lead to better health outcomes. Who this helps: This benefits Black prostate cancer survivors and their healthcare providers.

Plain English
This study looked at how well certain bacteria from the Dioscorea luzonensis plant can break down starch into glucose. The bacteria called Limosilactobacillus fermentum PJG11 performed the best, converting starch to glucose more efficiently due to increased production of a specific enzyme. This is important because it can lead to healthier functional foods that are easier for our bodies to digest and utilize for energy. Who this helps: This helps patients seeking better nutrition from functional foods.

Plain English
This study looked at how a protein called ABCA1, found in certain immune cells called myeloid cells, impacts the ability of these cells to fight cancer. Researchers discovered that when ABCA1 is active, it helps immune cells better infiltrate tumors and support other immune cells, which can improve the overall response to cancer treatments. Specifically, mice without ABCA1 in their immune cells had larger tumors and were more resistant to immune therapies, indicating that ABCA1 plays a critical role in cancer resistance. Who this helps: This benefits cancer patients by potentially improving immune therapies.

Plain English
A 15-month clinical trial in Chicago tested whether risk-tailored PSA screening guidelines — adjusted for race, family history, and prior PSA levels — could increase prostate cancer detection in a high-risk, majority-Black population. Screening rates nearly doubled, biopsies increased, and total prostate cancer diagnoses rose 2.7-fold, with no change in the proportion of aggressive tumors found. The results show that risk-adapted guidelines are practical in community health settings and can meaningfully increase cancer detection in underserved populations.

Plain English
This study looked at how different types of cells within luminal A breast cancer tumors can vary and how this affects patient outcomes. Researchers developed a deep learning tool that analyzed images from 680 breast cancer cases and found that tumors with a mix of cell types (or subtype admixture) were linked to more aggressive cancer characteristics, such as larger tumor size and lower levels of certain hormones; these cases also had shorter survival times. Understanding this mix helps to improve personalized treatment for breast cancer patients by identifying those who may have a poorer prognosis and need more targeted therapies. Who this helps: This benefits breast cancer patients and their doctors by providing insights for better treatment decisions.

Plain English
This study looked at how well prostate MRIs work for Black men compared to non-Black men, focusing on their ability to correctly identify whether a biopsy is needed. The researchers found that the MRIs had a negative predictive value of 77.1% for Black men versus 87.6% for non-Black men, meaning MRIs are less reliable in Black men. They also discovered that using a specific measurement called PSA density of 0.09 could help improve the accuracy for Black men, increasing the sensitivity to 92.9%. Who this helps: This research benefits Black men at risk for prostate cancer by providing better guidelines for when biopsies are necessary.

Plain English
This study looked at how prostate-specific antigen (PSA) levels at diagnosis have changed from 2004 to 2021, especially after new screening guidelines were introduced. Researchers analyzed data from nearly 946,000 prostate cancer cases and found that average PSA levels dropped until 2008, then stayed steady until 2011, before rising sharply again until around 2015. This increase in PSA levels corresponds with changes in guidelines that affected how and when men were screened for prostate cancer, which may lead to more advanced cases being diagnosed. Who this helps: This helps doctors and healthcare providers better understand trends in prostate cancer diagnosis and tailor their screening practices accordingly.

Plain English
Researchers studied a specific protein called ABCA1 in immune cells related to cancer, focusing on how it affects the way these cells support or fight tumors. They found that when ABCA1 is active in myeloid immune cells (like macrophages), it boosts their ability to attack tumors and helps other immune cells function better. In tests on mice, removing ABCA1 led to more tumor growth and spread, suggesting that adjusting this protein's activity could improve cancer treatment outcomes. Who this helps: This benefits cancer patients by potentially enhancing the effectiveness of immune therapies.

Plain English
This study developed and tested a new tool to help predict the risk of significant prostate cancer in Black men undergoing biopsies. They looked at data from 685 Black men and created three different models that showed good accuracy in risk assessment, with the best model correctly identifying 78% of cases while reducing the number of unnecessary biopsies. This specialized tool is important because it can lead to better decision-making for biopsies, ensuring more targeted and effective care for Black men who are at risk for prostate cancer. Who this helps: This helps Black men at risk for prostate cancer and their healthcare providers.

Plain English
This study looked at how to predict if prostate cancer will come back after treatment by analyzing tissue images. Researchers developed a method called PathCLR that analyzes these images and found that it could predict the likelihood of cancer recurrence within five years with an F1 score of 0.61 on one dataset and 0.85 on another, which is better than existing models based only on medical test results. This is important because it could help doctors provide better care by identifying which patients need closer monitoring or additional treatment based on their tissue samples at the time of surgery. Who this helps: Patients with prostate cancer.

Plain English
This study looked at how a protein called NR0B2 affects immune cells in the body, specifically those that can suppress the immune response in tumors. Researchers found that NR0B2 helps limit the growth of regulatory T cells, which are known to dampen the immune system's ability to fight tumors. Mice that did not have NR0B2 showed faster tumor growth, highlighting NR0B2's potential as a new target for cancer treatments. Who this helps: This research benefits cancer patients, particularly those with breast and solid tumors.

Plain English
This study looked at a protein called NR0B2 that helps the immune system fight cancer, particularly in breast tumors. Researchers found that when NR0B2 is present, patients tend to have better survival rates and a higher chance of benefiting from immune therapies. They developed a better treatment, DSHN-OMe, that is more effective at fighting tumors and regulating immune cells compared to earlier versions. Who this helps: This helps cancer patients, especially those with breast cancer, by improving treatment options.

Plain English
This study focused on a rare type of lymphoma called nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL), examining the role of a protein called polo-like kinase 1 (PLK1) in its growth. Researchers found that PLK1 was present in all 76 NLPHL samples studied, while less than 5% of classic Hodgkin lymphoma cases showed it. The presence of PLK1 was linked to more advanced disease, suggesting that targeting PLK1 could be a new treatment approach and that a strong immune response may help control tumor growth in NLPHL. Who this helps: This helps patients with nodular lymphocyte-predominant Hodgkin lymphoma and their doctors.

Plain English
This study looked at how vitamin D levels and a protein called megalin affect hormone levels in the prostate, especially in African American men. The researchers found that low vitamin D is linked to higher levels of testosterone and dihydrotestosterone (DHT) in the prostate. This matters because high androgen levels are connected to more aggressive prostate cancer, highlighting a possible reason for higher cancer rates in African American men. Who this helps: This research benefits patients, particularly African American men at risk for prostate cancer.

Plain English
This study looked at Luminal A (LumA) breast cancer and how mixing with other subtypes can influence patient outcomes. Researchers found that patients with LumA cancer that showed less LumA characteristics had a 27% higher chance of having a more advanced stage at diagnosis and nearly three times the likelihood of a specific gene mutation (TP53), which was linked to a significantly higher risk of death. Understanding these mixings can help doctors tailor treatment plans more effectively for individual patients. Who this helps: This benefits breast cancer patients and their doctors by providing insights for personalized treatment strategies.

Plain English
This study looked at tiny molecules called microRNAs found in the blood of prostate cancer patients to see if they could help doctors better assess cancer risk. Researchers found that levels of these microRNAs differed significantly between patients with less aggressive (indolent) cancer and those with more aggressive forms, improving existing risk calculators by providing clearer information about a patient's risk level. This matters because it could help doctors make more informed decisions about treatment options, especially for men with low-risk cancer, potentially helping them avoid unnecessary treatments. Who this helps: This helps patients with prostate cancer and their doctors by providing better risk assessment tools.

Plain English
This study focused on reducing grain chalkiness in rice, a quality issue that lowers market value and affects cooking quality. Researchers targeted a specific gene, V-PPase, and used advanced technology to reduce its activity, which resulted in a 20% reduction in chalk content and produced more translucent grains, especially under heat stress. This matters because improving grain quality can enhance the economic value of rice for farmers and producers. Who this helps: This helps rice farmers and consumers seeking higher-quality rice products.

Plain English
This study looked at how heart shape and function change in patients with chronic heart failure when they receive optimal medical treatment. Researchers tracked 57 patients over about 140 days and found significant improvements, like an increase in the heart’s pumping ability from 38.9% to 43.0%, along with reductions in heart size, indicating positive changes in heart structure. These findings are important because they suggest that the right treatments can help the heart recover in patients with chronic heart failure. Who this helps: This helps patients with chronic heart failure and their doctors.

Plain English
This study looked at how genomic testing, specifically the Oncotype Dx Genomic Prostate Score (GPS), affects urologists' decisions on treating men with low-risk prostate cancer. Researchers found that when urologists had access to GPS results, their preference for aggressive treatments like surgery or radiation increased significantly, nearly doubling from 14.1% to 29.3% (p=0.01). This matters because it shows that genomic testing can influence treatment choices, potentially leading more doctors to recommend treatments instead of monitoring the cancer closely. Who this helps: This helps patients with low-risk prostate cancer and their doctors by providing better information for treatment decisions.

Plain English
This study looked at a new type of MRI scan to help detect prostate cancer in men who had not yet undergone a biopsy. Out of 48 men who participated, prostate cancer was found in 7% of those with lower-risk MRI findings, while the detection rate increased to 36% for the highest-risk findings. This improvement in detection accuracy is important because it can lead to earlier and more effective treatment for prostate cancer. Who this helps: This helps patients, particularly those at risk for prostate cancer.

Plain English
This study focused on finding specific microRNAs in the blood of prostate cancer patients to see if they could help determine the risk level of the cancer more accurately than current methods, especially after a biopsy. Researchers found that measuring these microRNAs in tiny blood particles called extracellular vesicles improved the accuracy of risk predictions from an area under the curve (AUC) of 0.561 to 0.739, meaning it became much better at identifying aggressive forms of cancer. This is important because it helps doctors make more informed decisions about treatment options for patients with prostate cancer. Who this helps: This benefits patients with prostate cancer by providing better risk assessments.

Plain English
This study looked at how a specific protein called NR0B2 in immune cells can affect breast cancer progression. Researchers found that when NR0B2 was removed, breast tumors grew faster and spread more, but by using certain small molecules to stimulate NR0B2, they were able to reduce the growth of tumor-suppressing immune cells, slow down tumor growth, and improve cancer treatment effectiveness by reducing metastatic growth. This is important because it shows that targeting NR0B2 could help boost cancer therapies for breast cancer. Who this helps: This benefits breast cancer patients seeking more effective treatments.

Plain English
This study focused on improving how doctors measure PRMT6, a protein linked to how serious lung cancer can be, by using machine learning technology. The researchers developed an automated system that analyzes lung cancer tissue samples and found that it closely matched the accuracy of human pathologists, with a correlation score of 0.88 and a very high reliability rating of 0.96. This matters because it streamlines the process of evaluating a key cancer marker, making it faster and easier to identify patients at risk and tailor treatments. Who this helps: Patients with lung cancer and their doctors.

Plain English
This study looked at how certain genetic variations (polymorphisms) in enzymes affect the levels of hormones in breast tissue compared to the bloodstream. Researchers found that specific genetic factors influenced hormone concentrations in nipple aspirate fluid: for instance, one variation (CYP1B1) led to lower estradiol and higher progesterone levels, while another (HSD17B12) increased estradiol levels. These findings show that genetic differences can significantly impact local hormone levels in the breast, which is important for understanding breast health and disease. Who this helps: This helps patients, particularly those at risk for breast cancer or hormonal disorders.

Plain English
This study focused on improving how artificial intelligence (AI) diagnoses medical images by developing a new method called ClassClust, which helps the AI identify unusual cases, like those showing rare diseases or data collected in different ways. The researchers found that ClassClust was better at spotting these unusual images than three other methods, with a consistently higher accuracy rate and more helpful visual feedback about which parts of the images influenced the AI's decisions. This improvement is important because it can lead to better medical decisions and help ensure that doctors are alerted to cases that might be misinterpreted due to their rarity or differences. Who this helps: This helps doctors and healthcare providers by improving diagnostic accuracy for patients with rare or atypical conditions.

Plain English
This study looks at two different methods for weight loss and reducing the risk of colorectal cancer: daily calorie restriction and time-restricted eating. Researchers found that time-restricted eating led to a weight loss of about 3% to 5% among adults with obesity, while also improving factors like insulin sensitivity. Understanding the most effective ways to manage obesity is important because it can lower the chances of developing colorectal cancer. Who this helps: This research benefits patients with obesity at risk for colorectal cancer.

Plain English
This study looked at how a signaling pathway called Notch affects the development of aggressive lymphomas from mature T cells, specifically a type called peripheral T-cell lymphoma (PTCL). The researchers found that Notch signaling is active in many PTCL cases and that higher Notch1 activation is linked to increased cancer cell growth. Blocking Notch signaling in laboratory models slowed the progression of these lymphomas, suggesting that new treatments that target this pathway could be effective. Who this helps: Patients with aggressive T-cell lymphomas could benefit from new treatment strategies targeting Notch signaling.

Plain English
Researchers discovered that certain immune cells called macrophages play a critical role in helping a deadly blood cancer called peripheral T-cell lymphoma grow, and that cancer cells actively recruit and sustain these macrophages. They found that a drug called pacritinib, which blocks two specific proteins (CSF1R and JAK), can effectively eliminate these protective macrophages and slow cancer progression in laboratory models. This discovery opens a new treatment pathway for patients with this aggressive cancer by targeting not just the cancer cells themselves, but the immune system's support network that keeps them alive.

Plain English
This study looked at how well the Stockholm3 test detects higher-risk prostate cancer in men from different ethnic groups in the U.S. and Sweden. It found that 51% of African American men had higher-risk prostate cancer detected, compared to only 34% of their Swedish counterparts, which shows a significant difference (more than double the risk) in detection rates. This matters because it highlights the need for better tailored healthcare approaches to accurately identify and treat prostate cancer based on a patient's ethnic background. Who this helps: This helps patients, especially African American men, who may need more targeted screening for prostate cancer.

Plain English
Researchers studied the effectiveness of the Prostate Health Index in detecting certain types of prostate cancer in Black men who had never had a biopsy before. They found that about 32.9% of the men had Gleason grade group 2-5 prostate cancer, and using the Prostate Health Index could help avoid unnecessary biopsies in 33% of cases without missing too many cancers. This is important because it can reduce the number of invasive procedures for patients while still effectively identifying significant cancers. Who this helps: This benefits Black men at risk for prostate cancer.

Plain English
This study looked at how a genetic test called the Genomic Prostate Score (GPS) influenced treatment choices in mainly African American men with low-risk prostate cancer. Researchers found that overall, 77% of men who received the GPS test still chose active surveillance, but those with lower health literacy were much less likely to choose this option—only 11% did compared to 77% of those who didn’t get the test. This matters because it shows that while GPS can help some men understand their cancer better, it may discourage those with lower health knowledge from choosing safer treatment options. Who this helps: This research helps patients, especially those with lower health literacy, navigate their treatment choices better.

Plain English
This study looked at how genetic differences and the presence of a stress hormone receptor affect breast cancer. Researchers found that while certain genetic changes were associated with breast cancer traits, they were not statistically significant after further analysis. They also discovered that the glucocorticoid receptor (GCR) was found in normal breast tissue but was significantly lower in breast cancer samples, particularly linked to specific cell markers. Who this helps: This benefits breast cancer patients and their doctors by improving understanding of tumor characteristics and potential treatment responses.

Plain English
Researchers studied how different rice varieties develop grain chalkiness, which makes rice appear opaque. They found that certain genes responsible for starch production behave differently in chalky versus non-chalky rice, especially under heat stress. For example, chalky rice showed disrupted gene activity early in grain formation, leading to less efficient grain filling and more chalky grains. This is important because it can help breeders develop rice varieties that produce clearer, higher-quality grains, especially in warmer climates. Who this helps: This benefits rice farmers and consumers who prefer high-quality rice.

Plain English
Researchers studied how effectively deep learning technology can predict a specific genetic mutation (BRAF V600E) in thyroid cancer using images of cancer tissue, without needing detailed annotations about specific areas. They found that their model had an impressive accuracy rate of 98% when tested on 444 patients, which is significantly better than traditional methods that rely on expert annotations. This is important because it allows for faster and more cost-effective precision medicine, improving diagnosis and treatment options for thyroid cancer patients. Who this helps: This helps patients with thyroid cancer by improving the accuracy of their genetic testing.

Plain English
This study looked at two methods, the Prostate Health Index (PHI) and prostate-specific antigen (PSA) density, to see how well they improved the detection of significant prostate cancer after an advanced MRI scan. The research involved 143 men, of whom 55 (about 39%) had significant cancer. Using PHI helped avoid unnecessary biopsy procedures in 55% of cases without missing any significant cancers, showing it could be more effective than PSA density. Who this helps: This benefits patients who may avoid unnecessary biopsies while still getting accurate cancer diagnoses.

Plain English
A recent study focused on prostate cancer screening for African American men, who are more likely to be affected by the disease. The findings show that updated guidelines now recommend screening for high-risk men aged 55 to 69, shifting the recommendation from "D" (not recommended) to "C" (consideration advised). It’s important because early detection can significantly reduce the chance of dying from prostate cancer, yet many insurance plans do not cover these necessary support services to help men make informed decisions about screening. Who this helps: This benefits high-risk men, especially African American patients, and their doctors.

Plain English
This study focused on a new drug called telapristone acetate (TPA) to see how it affects early-stage hormone-sensitive breast cancer. Among the 61 women evaluated, those taking TPA showed a 5.5% decrease in a marker called Ki67, which suggests reduced tumor growth, compared to a 4.2% decrease in those taking a placebo. This matters because the results indicate that TPA may effectively slow down cancer cell growth, particularly in premenopausal women, pointing to the need for further research on this treatment. Who this helps: This helps patients with early-stage hormone-sensitive breast cancer looking for more effective treatment options.

Plain English
This study looked at a type of bacteria called Pseudomonas aeruginosa, focusing on a specific toxin called Exolysin A that may enhance the bacteria's ability to cause infections. The researchers analyzed 2439 drug-resistant strains and found that only 33 of them (1.5%) had the Exolysin A gene. While these strains showed some characteristics that make them more dangerous, like increased antibiotic resistance and better biofilm formation, they were still less harmful in lab tests compared to other more virulent strains. Who this helps: This research is important for doctors treating infected patients, especially those with wounds, as it informs them about the varying levels of risk from different strains of the bacteria.

Plain English
This study looked at a 17-gene test called the Oncotype DX Genomic Prostate Score (GPS) to see how well it predicts serious prostate cancer outcomes in African American (AA) and European American (EA) men. The researchers found that the GPS was a strong predictor of adverse pathology in both groups, meaning it can reliably indicate the likelihood of more severe cancer at surgery—26.7% of the men studied had adverse pathology. This is important because it shows that the GPS test works equally well for both AA and EA men, which can help doctors make better treatment decisions for their patients regardless of race. Who this helps: Patients with localized prostate cancer and their doctors.

Plain English
This study investigated whether a new antibody treatment, RPC4046, could reduce certain harmful cell changes in the esophagus of adults with eosinophilic esophagitis (EoE), a condition that can cause serious complications. Out of 69 patients treated for 16 weeks, those receiving the higher dose of RPC4046 showed a 4.24% reduction in harmful cell markers compared to those taking a placebo, while also experiencing significant improvements in tissue health and symptoms. These findings are important because they suggest this treatment can help stop the progression of EoE and its complications. Who this helps: This helps patients with eosinophilic esophagitis.

Plain English
This study looked at how to use a computer program to identify a specific protein associated with breast cancer called HER2, just by analyzing standard images of breast tissue that doctors commonly use. The researchers found that their method could accurately detect HER2 overexpression, achieving a success rate of 82% on test samples from one hospital and 76% on samples from another group. This is important because it offers a more affordable and reliable way to diagnose patients with HER2-positive breast cancer, especially in settings where more expensive tests are not practical. Who this helps: This helps patients with breast cancer, particularly those in areas with limited access to advanced testing.

Plain English
Researchers looked at a molecule called miR-182 to see if its levels in prostate tissue could help determine how dangerous a man's prostate cancer might be. They found that higher levels of miR-182 in cancerous tissue were linked to a lower risk of recurrence, with an odds ratio of 0.18, meaning that men with more of this molecule were less likely to have their cancer come back after treatment. This is important because it could help doctors predict which patients have a less aggressive form of the disease and tailor treatment accordingly. Who this helps: This helps patients with prostate cancer, especially those and their doctors looking to understand their cancer risk better.

Plain English
This study examined a type of breast cancer called Luminal A (LumA) to see how much variation exists within this subtype. Researchers analyzed data from nearly 2,000 cancer cases and found that LumA cancers that had mixed characteristics (admixed cases) tended to be diagnosed at an older age, had larger tumors, and showed worse outcomes than those classified as pure LumA. Specifically, admixed cases had a hazard ratio of 2.85 for overall survival, indicating significantly higher risk compared to pure cases. Who this helps: This research benefits patients with Luminal A breast cancer by identifying those at greater risk and helping doctors choose better treatment options.

Plain English
This study looked at the relationship between airborne metal pollution and the risk of different types of breast cancer. They found that women exposed to higher levels of metals like cadmium and antimony had a significantly increased risk of developing a specific type of breast cancer that does not have the estrogen and progesterone receptors, with cadmium showing more than double the odds (OR: 2.3). Understanding how these pollutants affect different breast cancer subtypes is important because it can help identify at-risk populations and guide public health measures. Who this helps: This research benefits patients, especially women at risk for breast cancer.

Plain English
This study looked at large cell neuroblastoma (LCN), an aggressive type of cancer that often appears in recurring cases of neuroblastoma. Researchers used high doses of chemotherapy delivered directly into tumors in mice and found that they could create LCN tumors and identify them using a digital analysis system. They achieved over 90% accuracy in identifying LCN with their model, which could lead to better detection of this cancer type in patients and help improve treatment outcomes. Who this helps: This benefits doctors and patients dealing with high-risk neuroblastoma.

Plain English
This study compared two different tools, the Prostate Cancer Prevention Trial Risk Calculator (PCPT) and the Prostate Biopsy Collaborative Group Risk Calculator (PBCG), to see which one better predicts prostate cancer risk in men of various racial backgrounds. Out of 954 men who had prostate biopsies, the PCPT helped avoid unnecessary biopsies in 68% of Black and Other men, compared to just 28% for the PBCG, with similar rates of missed significant cancers (23% for PCPT and 20% for PBCG). This matters because better predictive tools can help prevent unnecessary procedures and overdiagnosis, particularly in minority groups who are often affected by these issues. Who this helps: Patients, especially those from minority groups at risk of unnecessary biopsies.

Plain English
This study looked at how DNA methylation, a chemical process that can affect gene activity, is connected to aggressive types of breast cancer. Researchers found that the GSTM2 gene showed much higher methylation levels in tumors that were negative for estrogen and progesterone receptors—14% in non-invasive and 35% in invasive tumors, compared to just 2% and 3% in receptor-positive tumors. This finding is important because it suggests that GSTM2 hypermethylation could help identify patients at risk for more aggressive breast cancer, particularly in Black women, who were more likely to have these types of tumors. Who this helps: This helps patients, especially Black women at risk for aggressive breast cancer.

Plain English
This study looked at a protein called GPX1 found in prostate cells to see if its levels could predict whether prostate cancer would come back after treatment. Researchers compared GPX1 levels in tissue samples from men whose cancer recurred after surgery with those whose cancer did not return and found no connection between GPX1 levels and cancer recurrence. Even though GPX1 doesn’t appear to affect the chances of survival for these patients, this research shows it might have a new role inside the nucleus of prostate cells. Who this helps: This helps researchers and doctors studying prostate cancer treatments.